AMGN compared with TARS: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

TARSTarsus Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

TARSTarsus Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

TARS: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

AMGN, solidTARS, dashed

AMGNAmgen Inc

478.34· pre 479.81· delayed

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

TARSTarsus Pharmaceuticals, Inc.

68.92· pre 68.92· delayed

Pre-marketNov 5 '26delayed

Mkt cap$3.6BRevenue$195MQ3 FY26Revenue$451MFY25

Compare

Pre-marketNov 5 '26delayed

AMGNAmgen Inc

TARSTarsus Pharmaceuticals, Inc.

478.34pre 479.81delayed

Price

68.92pre 68.92delayed

$258.8B

Mkt cap

$3.6B

Q3 FY26$10.4B

Revenue

$195MQ3 FY26

FY25$36.8B

Revenue

$451MFY25

AMGN478.34vsTARS68.92Pre-marketNov 5 '26delayed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only TARS 6

ELANElanco Tiergesundheitsupplier

—Elancounlistedsupplier

—LianBio Ophthalmologyunlistedcustomer

—

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Xi An Grand Chang An Pharmaceutical

unlistedcustomer

2 more · TARS chain ›